Dapagliflozin Ameliorates Steatohepatitis by Restoring Ca2+ Homeostasis and Hepatic Insulin Signaling.

Amgalan B, Noh SW, Ryu HS, Kim YJ, Ahn HJ, Kim OH, Oh BC

Open source

DOI
10.4093/dmj.2026.0022
Published
2026 Nov 4
Container
Diabetes & metabolism journal
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4093/dmj.2026.0022,
  title = {Dapagliflozin Ameliorates Steatohepatitis by Restoring Ca2+ Homeostasis and Hepatic Insulin Signaling.},
  author = {Amgalan B and Noh SW and Ryu HS and Kim YJ and Ahn HJ and Kim OH and Oh BC},
  year = {2026},
  journal = {Diabetes \& metabolism journal},
  doi = {10.4093/dmj.2026.0022},
  url = {https://doi.org/10.4093/dmj.2026.0022}
}

RIS

TY  - JOUR
TI  - Dapagliflozin Ameliorates Steatohepatitis by Restoring Ca2+ Homeostasis and Hepatic Insulin Signaling.
AU  - Amgalan B
AU  - Noh SW
AU  - Ryu HS
AU  - Kim YJ
AU  - Ahn HJ
AU  - Kim OH
AU  - Oh BC
PY  - 2026
JO  - Diabetes & metabolism journal
DO  - 10.4093/dmj.2026.0022
UR  - https://doi.org/10.4093/dmj.2026.0022
ER  - 

APA

B, A., SW, N., HS, R., YJ, K., HJ, A., OH, K., & BC, O. (2026). Dapagliflozin Ameliorates Steatohepatitis by Restoring Ca2+ Homeostasis and Hepatic Insulin Signaling.. Diabetes & metabolism journal. https://doi.org/10.4093/dmj.2026.0022

Source records